Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...

A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from ...

A new review in Current Cardiology Reviews maps how heart failure management is shifting toward precision medicine—pairing proven therapies (notably SGLT2 inhibitors across the ejection fraction ...

Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...

In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...

Analyses identified a high-risk subgroup of patients – described as the ‘lemon-on-sticks’ phenotype – who had a high disease burden and poor outcomes, according to results presented today at Heart ...

Screening for heart failure with an AI-ECG algorithm could be particularly useful in places with limited access to more ...

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...

Some people with heart failure need to take multiple medicines each day in order to keep their symptoms under control. Heart failure not only leads to issues in the heart but other organs in the body ...

Decompensated heart failure (DHF) is heart failure that has worsened and needs immediate medical attention. It can develop in people with preexisting heart failure and those without signs of the ...